Cannabidiol (CBD) oils are low tetrahydrocannabinol products derived from Cannabis sativa
that have become very popular over the past few years. Patients report relief for a variety of …

Background Comprehensive literature reviews of historical perspectives and evidence
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …

Design A large retrospective case series at a psychiatric clinic involving clinical application
of CBD for anxiety and sleep complaints as an adjunct to usual treatment. The retrospective …

Cannabis research has historically focused on the most prevalent cannabinoids. However,
extracts with a broad spectrum of secondary metabolites may have increased efficacy and …

Epidemiological studies reveal that marijuana increases the risk of cardiovascular disease
(CVD); however, little is known about the mechanism. Δ 9-tetrahydrocannabinol (Δ 9-THC) …

BACKGROUND: The management of chronic pain is a complex challenge worldwide.
Cannabis-based medicines (CBMs) have proven to be efficient in reducing chronic pain …

Background: The political climate around Cannabis as a medicine is rapidly changing.
Legislators are adopting policies regarding appropriate medical applications, while the …

Cannabis products have recently regained much attention due to the high pharmacological
potential of their cannabinoid content. In this review, the most widely used sample …

Background Medicinal cannabis registries typically report pain as the most common reason
for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and …

Medicine continues to struggle in its approaches to numerous common subjective pain
syndromes that lack objective signs and remain treatment resistant. Foremost among these …